Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes
Tumors of the urogenital tract (prostate, kidney, bladder, and testes) can sometimes be related to genetic mutations that are present in all the cells of the body. Such mutations can be inherited and run in families. Therefore, it is relevant to obtain information on the incidence of all cancers in the family history. The information obtained may initiate genetic testing, leading to the identification of mutations that are related to cancer in the current or next generation. In addition, these mutations may offer alternative treatment options for patients.
Authors
- Zoran Čulig (ORCID: https://orcid.org/0000-0002-5001-6153)
- Antti Ranniko
- Lambertus A.L.M. Kiemeney (ORCID: https://orcid.org/0000-0002-2368-1326)
- Peter F.A. Mulders (ORCID: https://orcid.org/0000-0001-8562-6106)
- Alicia Katherine Morgans (ORCID: https://orcid.org/0000-0002-6563-4587)
- Renate Pichler (ORCID: https://orcid.org/0000-0001-5286-9048)
- Otto Hemminki (ORCID: https://orcid.org/0000-0002-3396-2391)
- Kari Hemminki (ORCID: https://orcid.org/0000-0002-2769-3316)
- Chris H. Bangma
Institutions
- Innsbruck Medical University (AT)
- Radboud University Nijmegen (NL)
- German Cancer Research Center (DE)
- Universität Innsbruck (AT)
- Charles University (CZ)
- Heidelberg University (DE)
- Radboud University Medical Center (NL)
- Dana-Farber Cancer Institute (US)
- Cancer Society of Finland (FI)
- Erasmus MC Cancer Institute (NL)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1016/j.euros.2024.08.011
- Citations
- 4
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.29
Funders
- Horizon 2020 Framework Programme